BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 7, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Coronavirus and DNA
American Association for the Advancement of Science

Researchers trace COVID-19’s family tree to battle outbreak and ‘infodemic’

Feb. 18, 2020
By Nuala Moran
SEATTLE – Tracing the family tree of COVID-19 through its evolving DNA sequence makes it possible to disprove many false claims circulating on social media about the novel coronavirus, and, in particular, that it was generated in a covert biological weapons program. “From everything I’ve looked at, there is zero evidence for genetic engineering; it looks like normal evolution,” said Trevor Bedford, a computational biologist at Fred Hutchinson Cancer Research Center, who has been using genomes sequences taken from patient samples to track the spread of the virus since Jan. 11.
Read More

Regulatory front for Feb. 18, 2020

Feb. 18, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: 10X Genomics, Bio-Rad Laboratories, Sanofi SA.
Read More
Target with off-center arrow

Medtronic misses Q3 revenue estimates, amid temporary drag in cardiac sales

Feb. 18, 2020
By Meg Bryant
Medtronic plc, of Dublin, blamed dampened demand for heart devices ahead of new product launches for its third-quarter revenue miss. Fiscal 2020 Q3 revenue totaled $7.72 billion, below Wall Street’s estimate of $7.81 billion, for organic sales growth of 2.6% vs. consensus and guidance of 4% or higher.
Read More

Other news to note for Feb. 18, 2020

Feb. 18, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aim, Audentes, Aytu, Brickell, DNX, Eyepoint, IBM, Innovate, Innovation, Innovus, Lytica, M8, Neuropore, 9 Meters, Oncodesign, Phosplatin, RDD, Revive, Saniona, Sanofi, Servier, Shanghai Hile, Stealth, Vaxil, Vectans, Vifor, Wuxi.
Read More
Coronavirus and DNA
American Association for the Advancement of Science

Researchers trace COVID-19’s family tree to battle outbreak and ‘infodemic’

Feb. 18, 2020
By Nuala Moran
SEATTLE – Tracing the family tree of COVID-19 through its evolving DNA sequence makes it possible to disprove many false claims circulating on social media about the novel coronavirus, and, in particular, that it was generated in a covert biological weapons program.
Read More

Other news to note for Feb. 18, 2020

Feb. 18, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Amarillo, Aptorum, Cipla, CNS Pharma, Codagenix, Cytodyn, Daewoong, Dr. Reddy’s, J&J, Jianjin University Haihe Hospital, Luye, M8 Pharma, Monash University, Recce, Synergy, Vir, Wockhardt, WPD Pharma, Xiamen Weiyang.
Read More

Regulatory front for Feb. 18, 2020

Feb. 18, 2020
The latest global regulatory news, changes and updates affecting biopharma, including: Sanofi, Sandoz.
Read More
Coronavirus and DNA
American Association for the Advancement of Science

Researchers trace COVID-19’s family tree to battle outbreak and ‘infodemic’

Feb. 14, 2020
By Nuala Moran
SEATTLE – Tracing the family tree of COVID-19 through its evolving DNA sequence makes it possible to disprove many false claims circulating on social media about the novel coronavirus, and, in particular, that it was generated in a covert biological weapons program. “From everything I’ve looked at, there is zero evidence for genetic engineering; it looks like normal evolution,” said Trevor Bedford, a computational biologist at Fred Hutchinson Cancer Research Center, who has been using genomes sequences taken from patient samples to track the spread of the virus since Jan. 11.
Read More
DNA illustration

Researchers develop diagnostic system that detects up to 40 infectious respiratory pathogens in one test

Feb. 14, 2020
By Elise Mak
BEIJING – Researchers from The Hong Kong Polytechnic University (PolyU) have developed a diagnostic system that they claim is the world’s most comprehensive as it can identify 30 to 40 pathogens in one single test within an hour.
Read More

Other news to note for Feb. 14, 2020

Feb. 14, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Assertio, Canagen, Collegium, Exicure, Genix, Melinta, Morphic, Recce, Vaxil.
Read More
Previous 1 2 … 527 528 529 530 531 532 533 534 535 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 6, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Ontrack Therapeutics divulges compounds for neurodegenerative diseases

    BioWorld Science
    Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
  • IPO puzzle pieces

    Neuracle eyes Shanghai IPO as global BCI funding surges

    BioWorld
    Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing